Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Does Harman International Industries Inc./DE/ (HAR) Represent A Good Investment?

Page 1 of 2

The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997. The two relatively short-lived corrections occurred at a time with stable interest rates, falling commodity markets, with strong-performing technology and healthcare sectors, and struggling energy sector. Similarly, the two corrections followed long periods without a correction, which had to come sooner or later and it did. Even so, several prominent hedge fund investors publicly asserted their bearish view on the current state of the U.S. equity markets, suggesting that they significantly cut their exposure to equities during the latest quarter. Having said that, it would be worthwhile to take a look at the hedge fund sentiment on Harman International Industries Inc./DE/ (NYSE:HAR) in order to identify whether reputable and successful top money managers continue to believe in its potential.

Is Harman International Industries Inc./DE/ (NYSE:HAR) undervalued? Hedge funds are turning bullish. The number of bullish hedge fund positions advanced by 10 recently. At the end of this article we will also compare HAR to other stocks including IDEXX Laboratories, Inc. (NASDAQ:IDXX), KT Corporation (ADR) (NYSE:KT), and Ashland Inc. (NYSE:ASH) to get a better sense of its popularity.

Follow Harman International Industries Inc (NYSE:HAR)
Trade (NYSE:HAR) Now!

According to most traders, hedge funds are assumed to be underperforming, old investment tools of the past. While there are greater than 8000 funds with their doors open at the moment, we hone in on the aristocrats of this club, around 700 funds. These hedge fund managers manage the lion’s share of the hedge fund industry’s total capital, and by monitoring their inimitable stock picks, Insider Monkey has formulated numerous investment strategies that have historically outperformed Mr. Market. Insider Monkey’s small-cap hedge fund strategy outperformed the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Now, we’re going to take a peek at the new action encompassing Harman International Industries Inc./DE/ (NYSE:HAR).

How have hedgies been trading Harman International Industries Inc./DE/ (NYSE:HAR)?

Heading into Q4, a total of 27 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 59% from the second quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, AQR Capital Management, managed by Cliff Asness, holds the largest position in Harman International Industries Inc./DE/ (NYSE:HAR). AQR Capital Management has a $80.4 million position in the stock, comprising 0.2% of its 13F portfolio. The second largest stake is held by Edinburgh Partners, managed by Sandy Nairn, which holds a $77.8 million position; the fund has 8.2% of its 13F portfolio invested in the stock. Some other hedge funds and institutional investors that hold long positions encompass Clifford Fox’s Columbus Circle Investors, Hugh Sloane’s Sloane Robinson Investment Management and Israel Englander’s Millennium Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!